Analysen zu RELX PLC (ex Reed Elsevier)
| 26.03.25 | RELX Buy | Goldman Sachs Group Inc. | |
| 20.03.25 | RELX Buy | UBS AG | |
| 14.03.25 | RELX Overweight | Barclays Capital | |
| 21.02.25 | RELX Buy | UBS AG | |
| 18.02.25 | RELX Overweight | JP Morgan Chase & Co. | |
| 14.02.25 | RELX Hold | Deutsche Bank AG | |
| 14.02.25 | RELX Buy | UBS AG | |
| 14.02.25 | RELX Outperform | Bernstein Research | |
| 11.02.25 | RELX Outperform | Bernstein Research | |
| 21.01.25 | RELX Overweight | JP Morgan Chase & Co. | |
| 15.01.25 | RELX Outperform | Bernstein Research | |
| 11.12.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 08.11.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 31.10.24 | RELX Buy | UBS AG | |
| 24.10.24 | RELX Outperform | Bernstein Research | |
| 10.10.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 26.07.24 | RELX Buy | UBS AG | |
| 17.07.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 28.06.24 | RELX Equal Weight | Barclays Capital | |
| 14.05.24 | RELX Buy | UBS AG | |
| 25.04.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 25.04.24 | RELX Buy | Goldman Sachs Group Inc. | |
| 25.04.24 | RELX Buy | UBS AG | |
| 18.04.24 | RELX Buy | UBS AG | |
| 11.04.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 01.03.24 | RELX Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.02.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 15.02.24 | RELX Buy | UBS AG | |
| 29.01.24 | RELX Equal Weight | Barclays Capital | |
| 22.01.24 | RELX Buy | UBS AG | |
| 16.01.24 | RELX Buy | Goldman Sachs Group Inc. | |
| 08.01.24 | RELX Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.01.24 | RELX Buy | UBS AG | |
| 10.11.23 | RELX Equal Weight | Barclays Capital | |
| 19.10.23 | RELX Overweight | JP Morgan Chase & Co. | |
| 19.10.23 | RELX Buy | UBS AG | |
| 04.10.23 | RELX Buy | Goldman Sachs Group Inc. | |
| 02.10.23 | RELX Equal Weight | Barclays Capital | |
| 27.09.23 | RELX Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.09.23 | RELX Overweight | JP Morgan Chase & Co. | |
| 13.09.23 | RELX Overweight | JP Morgan Chase & Co. | |
| 08.09.23 | RELX Buy | UBS AG | |
| 08.09.23 | RELX Equal Weight | Barclays Capital | |
| 31.07.23 | RELX Neutral | Goldman Sachs Group Inc. | |
| 28.07.23 | RELX Equal Weight | Barclays Capital | |
| 28.07.23 | RELX Hold | Deutsche Bank AG | |
| 28.07.23 | RELX Neutral | Goldman Sachs Group Inc. | |
| 27.07.23 | RELX Overweight | JP Morgan Chase & Co. | |
| 27.07.23 | RELX Buy | UBS AG | |
| 19.07.23 | RELX Buy | UBS AG |
Aktuelle Aktienanalysen
| 07.04.25 | TRATON Neutral | JP Morgan Chase & Co. | |
| 07.04.25 | AB InBev Overweight | JP Morgan Chase & Co. | |
| 07.04.25 | Nutrien Neutral | UBS AG | |
| 07.04.25 | Ahold Delhaize Hold | Jefferies & Company Inc. | |
| 07.04.25 | Evonik Neutral | UBS AG | |
| 07.04.25 | LANXESS Neutral | UBS AG | |
| 07.04.25 | WACKER CHEMIE Buy | UBS AG | |
| 07.04.25 | ING Group Buy | UBS AG | |
| 07.04.25 | Deutsche Bank Buy | UBS AG | |
| 07.04.25 | Befesa Buy | Jefferies & Company Inc. | |
| 07.04.25 | Fraport Neutral | UBS AG | |
| 07.04.25 | Apple Neutral | UBS AG | |
| 07.04.25 | Roche Buy | UBS AG | |
| 07.04.25 | Gerresheimer Kaufen | DZ BANK | |
| 07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.04.25 | Sanofi Hold | Deutsche Bank AG | |
| 07.04.25 | Novartis Buy | Deutsche Bank AG | |
| 07.04.25 | GSK Hold | Deutsche Bank AG | |
| 07.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 07.04.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 07.04.25 | BNP Paribas Outperform | RBC Capital Markets | |
| 07.04.25 | Brenntag Add | Baader Bank | |
| 07.04.25 | FUCHS Add | Baader Bank | |
| 07.04.25 | Givaudan Add | Baader Bank | |
| 07.04.25 | FedEx Buy | Deutsche Bank AG | |
| 07.04.25 | Symrise Add | Baader Bank | |
| 07.04.25 | KWS SAAT Buy | Baader Bank | |
| 07.04.25 | Fresenius Market-Perform | Bernstein Research | |
| 07.04.25 | WACKER CHEMIE Add | Baader Bank | |
| 07.04.25 | Siemens Healthineers Outperform | Bernstein Research | |
| 07.04.25 | K+S Add | Baader Bank | |
| 07.04.25 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 07.04.25 | Roche Sell | Deutsche Bank AG | |
| 07.04.25 | TUI Market-Perform | Bernstein Research | |
| 07.04.25 | London Stock Exchange Buy | UBS AG | |
| 07.04.25 | Deutsche Börse Buy | UBS AG | |
| 07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.04.25 | Prosus Buy | Deutsche Bank AG | |
| 07.04.25 | Redcare Pharmacy Buy | Deutsche Bank AG | |
| 07.04.25 | SAFRAN Overweight | Barclays Capital | |
| 07.04.25 | MTU Aero Engines Equal Weight | Barclays Capital | |
| 07.04.25 | Airbus Overweight | Barclays Capital | |
| 07.04.25 | QIAGEN Buy | Deutsche Bank AG | |
| 07.04.25 | Shell Outperform | RBC Capital Markets | |
| 07.04.25 | RWE Overweight | JP Morgan Chase & Co. | |
| 07.04.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.04.25 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
| 07.04.25 | DHL Group Hold | Warburg Research | |
| 07.04.25 | Deutsche Bank Overweight | JP Morgan Chase & Co. | |
| 07.04.25 | Barclays Overweight | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.